https://charts.traderzeitung.de/phases/US45258D1054
string(1376) "{"isin":"US45258D1054","name":"Immunocore Holdings PLC","stock_id":19105652,"generated_at":"2026-11-03 19:10:00","days":[{"date":"2026-10-30","dst_offset":5,"phases":[{"phase":1,"label":"pre","from":"09:00","to":"14:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"14:30","to":"21:00","close":30.44,"close_at":"2026-10-30 20:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"21:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-11-02","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":29.76,"close_at":"2026-11-02 21:59:00","complete":true,"perf_pct":-2.2339},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-11-03","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":30.12,"close_at":"2026-11-03 19:02:00","complete":false,"perf_pct":1.2097},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
array (
'data' =>
array (
'isin' => 'US45258D1054',
'name' => 'Immunocore Holdings PLC',
'stock_id' => 19105652,
'generated_at' => '2026-11-03 19:10:00',
'days' =>
array (
0 =>
array (
'date' => '2026-10-30',
'dst_offset' => 5,
'phases' =>
array (
0 =>
array (
'phase' => 1,
'label' => 'pre',
'from' => '09:00',
'to' => '14:30',
'close' => NULL,
'close_at' => NULL,
'complete' => true,
'perf_pct' => NULL,
),
1 =>
array (
'phase' => 2,
'label' => 'regular',
'from' => '14:30',
'to' => '21:00',
'close' => 30.44,
'close_at' => '2026-10-30 20:59:00',
'complete' => true,
'perf_pct' => NULL,
),
2 =>
array (
'phase' => 3,
'label' => 'post',
'from' => '21:00',
'to' => '26:00',
'close' => NULL,
'close_at' => NULL,
'complete' => true,
'perf_pct' => NULL,
),
),
),
1 =>
array (
'date' => '2026-11-02',
'dst_offset' => 6,
'phases' =>
array (
0 =>
array (
'phase' => 1,
'label' => 'pre',
'from' => '10:00',
'to' => '15:30',
'close' => NULL,
'close_at' => NULL,
'complete' => true,
'perf_pct' => NULL,
),
1 =>
array (
'phase' => 2,
'label' => 'regular',
'from' => '15:30',
'to' => '22:00',
'close' => 29.76,
'close_at' => '2026-11-02 21:59:00',
'complete' => true,
'perf_pct' => -2.2339,
),
2 =>
array (
'phase' => 3,
'label' => 'post',
'from' => '22:00',
'to' => '26:00',
'close' => NULL,
'close_at' => NULL,
'complete' => true,
'perf_pct' => NULL,
),
),
),
2 =>
array (
'date' => '2026-11-03',
'dst_offset' => 6,
'phases' =>
array (
0 =>
array (
'phase' => 1,
'label' => 'pre',
'from' => '10:00',
'to' => '15:30',
'close' => NULL,
'close_at' => NULL,
'complete' => true,
'perf_pct' => NULL,
),
1 =>
array (
'phase' => 2,
'label' => 'regular',
'from' => '15:30',
'to' => '22:00',
'close' => 30.12,
'close_at' => '2026-11-03 19:02:00',
'complete' => false,
'perf_pct' => 1.2097,
),
2 =>
array (
'phase' => 3,
'label' => 'post',
'from' => '22:00',
'to' => '26:00',
'close' => NULL,
'close_at' => NULL,
'complete' => true,
'perf_pct' => NULL,
),
),
),
),
),
'success' => true,
)
Immunocore Holdings Aktie News & Nachrichten
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Artikel aus der Redaktion der Trader-Zeitung
27.05.2025 um 15 Uhr
Immunocore Holdings plc (IMCR) ist ein biopharmazeutisches Unternehmen mit Sitz in Oxfordshire, Großbritannien,...
27.05.2025 um 14 Uhr
Liquida Technologies [US53635D2027]: Bank of America bekräftigt Buy-Rating und erhöht das Kursziel...
